Inspharmtech, Inc.
PrivateLast Round
Grant
Jun 1, 2023
Total Funding Raised
$1.15M
Company Overview
Inspharmtech, Inc. is a biopharmaceutical company that develops first-in-class small-molecule therapeutics for age-related diseases, including age-related macular degeneration and osteoarthritis.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical Devices
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Inspharmtech, Inc. Comparables
Compare Inspharmtech, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Re-Vana Therapeutics | 84% | |
| Olive Bio Therapeutics | 81% | |
| NexThera Co., Ltd. | 78% |
Inspharmtech, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 1, 2023 |
Inspharmtech, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Government of South Korea | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 1, 2023
$1.15M grant from the Government of South Korea
Inspharmtech, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Inspharmtech, Inc.'s valuation, stock price, and market status.
Is Inspharmtech, Inc. a public or private company?
Inspharmtech, Inc. is a private company.
What is the current stock price of Inspharmtech, Inc.?
Inspharmtech, Inc. is a private company with no public stock price. Caplight tracks Inspharmtech, Inc.'s secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is Inspharmtech, Inc. worth (valuation)?
Valuation information for Inspharmtech, Inc. is not publicly available.
Can I buy Inspharmtech, Inc. stock?
Inspharmtech, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Inspharmtech, Inc.'s last funding round?
Inspharmtech, Inc.'s most recent funding round was Grant on June 1, 2023.
Who are the main investors in Inspharmtech, Inc.?
Key investors in Inspharmtech, Inc. include Government of South Korea.
Will Inspharmtech, Inc. IPO soon?
No public IPO plans have been announced for Inspharmtech, Inc..
How can I track Inspharmtech, Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Inspharmtech, Inc.'s secondary market activity and sign up for updates.